|
||
|
Management Profiles Mohan Philip, Ph.D. , MBA, Chief Operating Officer Prior
to cofounding Immunotope, Dr.
Philip was Chief Scientific Officer of RHeoGene LLC beginning with its formation
in July 1999. Prior to RHeoGene, he was Vice President for Gene Therapy Research
at Argonex Inc., one of the two parent companies of RHeoGene. Prior to Argonex,
Dr. Philip was the head of Vector Development and Oncology Department at Rhone
Poulenc Rorer Gencell. Dr. Philip joined RPR Gencell in 1993 and had a key role
in several gene therapy projects. He developed pMP6/Avectin vectors that were
used in three approved clinical trials. In addition to overseeing vector
development activities for p53, suicide/immunotherapy and antiangiogenesis
projects, he also initiated the vector-targeting program at Gencell. From 1988
to 1993 he was a research scientist at Neurex Corporation, where he had a
leadership role in cloning neuron specific calcium channels. Dr. Philip was also
an Associate Professor of Research in Internal Medicine at the
|
|
..................................................................................................................................................................... |